HemoGenix is the only company worldwide that specialises in stem cell hemotoxicity testing for the biotechnology, pharmaceutical and research industry. HemoGenix offers an extensive line of in vitro testing assay kits to detect the response of primary cells to virtually any agent.

The HemoGenix product range includes:

• CAMEO-4, miniaturised version of the colony-forming cell (CFC) assay in kit form
• CAMEO-96 STD, the first and only standardised CFC potency assay
• HALO, fully standardised lympho-hematopoietic proliferation assay
• LUMENESC, for the mesenchymal stem cell (MSC) system
• LumiSTEM, for non-hematopoietic and non-MSC system cells
• ComparaTOX, a predictive in vitro cross-platform, comparative toxicity test that combines HALO, LUMENESC and LumiSTEM
• OxyFLOW, for the detection of oxidative DNA damage by flow cytometry
• In Vitro Tissue Culture products, the POC, POC-R and POCmini Chamber Systems, FoilCover and many more

HemoGenix’s Assay Kits and Contract Research Services have been designed for 4 primary application arenas:

• Basic Research
• Quality Control in Stem Cell Transplantation and Cord Blood Storage Processing Laboratories
• Drug Discovery and Development
• Environmental / Xenobiotic Testing